Dr. Shyam Maharaj

Division of Respirology

Shyam Maharaj

RPh, BSc Pharm, M. Phil (Pharmacology), PhD (Medical Sciences)

Assistant Clinical Professor (Adjunct), Division of Respirology, Department of Medicine

Clinical Pharmacist, St Joseph’s HealthCare Hamilton

 

 

 

 

 

Education and Professional Standing

Dr. Maharaj is a Clinical Pharmacist at St. Joseph’s Health Care Hamilton, an Adjunct Assistant Clinical Professor with the Department of Medicine at McMaster University, a Clinical Preceptor for the University of Waterloo and Examiner for the undergraduate Pharmacy programs at University of Waterloo (bridging program) and the University of the West Indies (UWI) St. Augustine campus. He trained as a Pharmacist and subsequently obtained his Master of Philosophy in Pharmacology at UWI. He pursued his PhD in Medical Sciences at McMaster University and is an alumnus of the Canadian Institutes of Health Research DSECT program.

Research Interests

Dr. Maharaj’s research focus is the adverse outcomes of medication therapy. His PhD research examined potential contributors to lung fibrosis including the pulmonary toxicity of some medications. His current Pharmacy Practice focuses on Geriatric Medicine; he is actively involved in projects aimed at improving safe prescribing practices and assessing the impact of polypharmacy on the senior population.   

Selected Publications

  1. Calvin Hirsch, Shyam Maharaj and James Bourgeois. The chief adverse effects of medication. A Hatgean, C. Hirsch, A. and J. Bourgeios (Eds). On Call Geriatric Psychiatry-A Handbook of Principles and Practice. Springer, New York, 2016.
  2. Alhamad EH, Shakoor Z, Al-Kassimi FA, Almogren A, Gad ElRab MO, Maharaj S, Kolb M. Rapid detection of circulating fibrocytes by flow cytometry in idiopathic pulmonary fibrosis. Ann Thorac Med. 2015 Oct-Dec; 10(4): 279-83.
  3. Fibrocytes in Pulmonary Fibrosis – A Brief Synopsis. Shyam Maharaj, Chiko Shimbori and Martin Kolb. Eur Respir Rev. 2013 Dec; 22(130):552-7
  4. Clinical Trials in Idiopathic Pulmonary Fibrosis: Update and Perspectives Eva Baroke, Shyam Maharaj, Martin Kolb. Future Science: Clinical Investigation 1(12): 1669, December 2011.
  5. Local Delivery of GM-CSF Protects Mice from Lethal Pneumococcal Pneumonia. Steinwede K, Tempelhof O, Bolte K, Maus R, Bohling J, Ueberberg B, Länger F, Christman JW, Paton JC, Ask K, Maharaj S, Kolb M, Gauldie J, Welte T, Maus UA. J Immunol. 2011 Nov 15; 187(10):5346-56.
  6. Fibrocytes in chronic lung disease-Facts and controversies. Maharaj SS, Baroke E, Gauldie J, Kolb MR. Pulm Pharmacol Ther. 2011 Sep 20.
  7. Oxidative stress contributes to the induction and persistence of TGF-β1 induced pulmonary fibrosis. Ye Cui, Jennifer Robertson, Shyam Maharaj, Lisa Waldhauser, J Nui, J Wang, Laszlo Farkas, Martin R.J. Kolb, and Jack Gauldie. Int J Biochem Cell Biol. April 14 2011.